
TwoStep Therapeutics is a biotechnology company developing a pipeline built around a unique tumor-targeting polyspecific integrin-binding peptide (PIP) that can selectively bind several targets that are highly expressed on solid tumors.
TwoStep Therapeutics is seeking a Chief Medical Officer to oversee and advance a differentiated pipeline of targeted drug conjugates and radioligand therapies designed to address high unmet needs across multiple solid tumor indications.
TwoStep Therapeutics is a biotechnology company developing a pipeline built around a unique tumor-targeting polyspecific integrin-binding peptide (PIP) that can selectively bind several targets that are highly expressed on solid tumors.